Aytu BioPharma
Aytu BioPharma's Q4 2025 Earnings: Anticipation Mounts Ahead of Key EXXUA Launch
NEW YORK, NY – September 23, 2025 – As the trading day concludes, all eyes in the biopharmaceutical sector are turning to Aytu BioPharma (NASDAQ: AYTU), which is poised to release its fiscal fourth-quarter and full-year 2025 operational and financial results after market close today. Investors and analysts are keenly awaiting these